Boston Scientific Corporation (FRA:BSX)
86.60
-0.20 (-0.23%)
At close: Nov 28, 2025
Boston Scientific Market Cap
Boston Scientific has a market cap or net worth of €128.81 billion as of December 2, 2025. Its market cap has increased by 4.12% in one year.
Market Cap
128.81B
Enterprise Value
138.27B
Revenue
16.49B
Ranking
n/a
PE Ratio
54.15
Stock Price
€86.60
Market Cap Chart
Since May 19, 1992, Boston Scientific's market cap has increased from 1.25B to 128.81B, an increase of 10,207.30%. That is a compound annual growth rate of 14.81%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 1, 2025 | 128.81B | 1.30% |
| Dec 31, 2024 | 127.15B | 65.95% |
| Dec 29, 2023 | 76.62B | 23.56% |
| Dec 30, 2022 | 62.01B | 16.50% |
| Dec 31, 2021 | 53.23B | 26.48% |
| Dec 31, 2020 | 42.08B | -25.07% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Merck KGaA | 50.43B |
| Siemens Healthineers AG | 47.80B |
| Bayer Aktiengesellschaft | 29.95B |
| Fresenius SE & Co. KGaA | 26.66B |
| Sartorius Aktiengesellschaft | 15.41B |
| Fresenius Medical Care AG | 11.88B |
| Carl Zeiss Meditec AG | 3.90B |
| Fielmann Group AG | 3.68B |